| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 02/28/2006 | CA2173116C Ring-expanded nucleosides and nucleotides |
| 02/23/2006 | WO2006020276A2 Antiviral compounds |
| 02/23/2006 | WO2006020082A1 Inhibitors of hcv replication |
| 02/23/2006 | WO2006020071A2 Vaccines against aids comprising cmv/r-nucleic acid constructs |
| 02/23/2006 | WO2006019955A2 Antiviral methods and compositions |
| 02/23/2006 | WO2006019832A1 Thienopyridines for treating hepatitis c |
| 02/23/2006 | WO2006019831A1 Methods for treating hepatitis c |
| 02/23/2006 | WO2006018807A1 Crystalline forms of cefdinir |
| 02/23/2006 | WO2006018682A2 Oxazolidinone derivatives as antimicrobials |
| 02/23/2006 | WO2006018544A1 Composition containing a thiophenic or benzothiophenic compound and exhibiting a pump nora inhibiting activity |
| 02/23/2006 | WO2006018185A2 Dihydropteridinones for the treatment of cancer diseases |
| 02/23/2006 | WO2005105843A3 Hiv protease inhibitors |
| 02/23/2006 | WO2005069771A3 Small molecule antagonists of bcl-2 family proteins |
| 02/23/2006 | WO2004071458A3 REGULATION OF FOOD INTAKE AND GLUCOSE PRODUCTION BY MODULATION OF LONG-CHAIN FATTY ACYL-CoA LEVELS IN THE HYPOTHALAMUS |
| 02/23/2006 | WO2004067018A8 Bioavailability enhancing activity of carum carvi extracts and fractions thereof |
| 02/23/2006 | WO2003086277A9 Attenuated gram negative bacteria |
| 02/23/2006 | US20060041123 Antibacterial agents |
| 02/23/2006 | US20060041107 Mutants of streptococcal toxin A and methods of use |
| 02/23/2006 | US20060040995 Method for preparing hydroxypicolinic scid derivatives |
| 02/23/2006 | US20060040992 Antiinflammatory 3-arylthio-3-thiazolyl-alkylamines |
| 02/23/2006 | US20060040925 Aminocyclohexene quinolines and their azaisosteric analogues with antibacterial activity |
| 02/23/2006 | US20060040923 1,1-Diethyl-3-(2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-urea; respiratory syncytial virus; cost efficient replacement for Synagis (palivizumab) used for RSV; respiratory system disorders; asthna; viral diseases; myxoviruses; mumps; flaviviruses; dengue, West Nile, parainfluenza viruses |
| 02/23/2006 | US20060040916 Carbapenem compound crystals and injection preparations |
| 02/23/2006 | US20060040914 Meso-substituted porphyrins |
| 02/23/2006 | US20060040912 Compounds for pdt |
| 02/23/2006 | US20060040903 Methods of use related to xerostomia |
| 02/23/2006 | US20060040891 Lipid a and other carbohydrate ligand analogs |
| 02/23/2006 | US20060040869 Pharmaceutically useful compounds |
| 02/23/2006 | US20060040362 Recombinant human Mannan-Building Proteins |
| 02/23/2006 | US20060040331 Methods of screening apoptosis modulating compounds, compounds identified by said methods and use of said compounds as therapeutic agents |
| 02/23/2006 | US20060040313 Human chemokine beta-9 |
| 02/23/2006 | US20060039988 Azithromycin dosage forms with reduced side effects |
| 02/23/2006 | US20060039969 Gastrointestinal side effect reduction with lower mean Maximum concentrations (Cmax) than with an immediate release formulation, but equivalent bioavailability of clarithromycin and a water soluble alginate salt, a complex salt of alginic acid and an organic carboxylic acid |
| 02/23/2006 | US20060039953 Water soluble polymer such as pullulan and an antimicrobial effective amount of thymol, methyl salicylate, eucalyptol and/or menthol; killing the plaque-producing germs that cause dental plaque, gingivitis and bad breath |
| 02/23/2006 | US20060039927 Specific binding agents for KSHV vIL-6 that neutralize a biological activity |
| 02/23/2006 | US20060039925 Mutants of streptococcal toxin a and methods of use |
| 02/23/2006 | US20060039922 Streptococcal heat shock proteins of the Hsp60 family |
| 02/23/2006 | US20060039920 Immunization, scrub typhus of tsutsugamushi disease, HIV |
| 02/23/2006 | US20060039918 Stress proteins and peptides and methods of use thereof |
| 02/23/2006 | US20060039909 Human CD28 specific monoclonal antibodies for antigen-non-specific activation of T-lymphocytes |
| 02/23/2006 | DE20023745U1 Method of modulating expression of an endogenous cellular gene in a cell to prevent gene activation or prevent repression of gene expression comprising contacting a target sequence with a zinc finger protein |
| 02/23/2006 | DE102004039280A1 1,5-Diphenyl-pyrazole 1,5-diphenyl-pyrazoles |
| 02/23/2006 | DE102004037911A1 New mixed cage dimers of 4-phenyl-1,4-dihydropyridine derivatives, useful as HIV-1 protease inhibiting anti-HIV agents which also modulate HIV resistance by inhibiting P-glycoprotein |
| 02/23/2006 | DE102004037885A1 New cage dimers of 4-phenyl-1,4-dihydropyridine derivatives, useful as HIV-1 protease inhibiting anti-HIV agents and for increasing resorption and bioavailability of other anti-HIV drugs |
| 02/23/2006 | CA2578636A1 Thienopyridines for treating hepatitis c |
| 02/23/2006 | CA2578189A1 Method for determining dosage for an oral killed vaccine |
| 02/23/2006 | CA2577597A1 Methods of diagnosis and treatment of m. tuberculosis infection and reagents therefor |
| 02/23/2006 | CA2577274A1 Anti-inflammatory agents |
| 02/23/2006 | CA2577183A1 Mutated hiv nef for modulating immunity |
| 02/23/2006 | CA2576421A1 Inhibitors of hcv replication |
| 02/23/2006 | CA2575787A1 Dihydropteridinones for the treatment of cancer diseases |
| 02/23/2006 | CA2573185A1 Methods for treating hepatitis c |
| 02/23/2006 | CA2558289A1 Peptides for the treatment of herpes virus infections |
| 02/22/2006 | EP1627919A1 An infectious cDNA clone of North American porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof |
| 02/22/2006 | EP1627883A1 9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin A derivatives |
| 02/22/2006 | EP1627880A1 Boronic ester and acid compounds, synthesis and uses |
| 02/22/2006 | EP1627663A2 Use of a pharmaceutical composition for the treatment of pathologies derived from infection by herpes virus, papillomavirus, hepatitis virus, viral neuralgia, viral dsyplasia, immune-deficiency-induced viral infections and viral neuritis. |
| 02/22/2006 | EP1627641A1 Pharmaceutical compositions comprising metal oxides and uses thereof |
| 02/22/2006 | EP1627637A1 Ophthalmic solution containing quinolone antimicrobial compound |
| 02/22/2006 | EP1627635A2 Benzothiazolium compounds for use in methods of inhibiting NO production and TNF alpha and treating coronaviral infection |
| 02/22/2006 | EP1627055A2 Novel uses of ppar modulators and professional apcs manipulated by the same |
| 02/22/2006 | EP1627048A2 Compositions for down-regulation of ccr5 expression and methods of use therefor |
| 02/22/2006 | EP1626736A1 C1 inhibitor with short half-life for transient treatment |
| 02/22/2006 | EP1626734A2 Uses of interferons for the treatment of severe acute respiratory syndrome and other viral infections |
| 02/22/2006 | EP1626694A2 Vaccine accelerator factor (vaf) for improvement of vaccinations in poultry |
| 02/22/2006 | EP1441735B1 N-substituted hydroxypyrimidinone carboxamide inhibitors of hiv integrase |
| 02/22/2006 | EP1434882A4 Aptamers containing sequences of nucleic acids or nucleic acid analogues bound homologously, or in novel complexes |
| 02/22/2006 | EP1414812B1 Hydroxamic acid derivatives |
| 02/22/2006 | EP1406622B1 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 02/22/2006 | EP1392704B1 Cephem compounds |
| 02/22/2006 | EP1385839B1 3-substituted quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists |
| 02/22/2006 | EP1237874B1 Selective neurokinin antagonists |
| 02/22/2006 | EP1194584B1 Method for producing oligopolysaccharides |
| 02/22/2006 | EP1121156B1 Polymer conjugates of interferon beta- 1a and their uses |
| 02/22/2006 | EP1109564B1 Method for removal of hiv and other viruses from blood |
| 02/22/2006 | EP1062336B1 Modulators of the function of receptors of the tnf/ngf receptor family |
| 02/22/2006 | EP1051193B1 Anhydrous topical skin preparation comprising ketoconazole |
| 02/22/2006 | EP1003844B1 Kinase activating dependent cyclin protein kinases, and their uses |
| 02/22/2006 | EP0549615B1 Sugar modified oligonucleotides that detect and modulate gene expression |
| 02/22/2006 | CN1738898A Antimicrobial activity of antibodies producing reactive oxygen species |
| 02/22/2006 | CN1738834A Hcv 疫苗 Hcv vaccine |
| 02/22/2006 | CN1738833A Hcv疫苗 Hcv vaccine |
| 02/22/2006 | CN1738832A Ligands |
| 02/22/2006 | CN1738829A New 2',5'-oligoadenylic acid analog |
| 02/22/2006 | CN1738816A Substituted indolepyridinium as anti-infective compounds |
| 02/22/2006 | CN1738802A Antibiotics containing borinic acid complexes and methods of use |
| 02/22/2006 | CN1738794A Biguanide and dihydrotriazine derivatives |
| 02/22/2006 | CN1738788A Substituted phenyl naphthalenes as estrogenic agents |
| 02/22/2006 | CN1738637A DC-SIGN blockers and their use for preventing or treating viral infections. |
| 02/22/2006 | CN1738635A Method of treating hepatitis virus infection with a multiphasic interferon delivery profile |
| 02/22/2006 | CN1738632A Bioavailability enhancing activity of carum carvi extracts and fractions thereof |
| 02/22/2006 | CN1738599A Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds |
| 02/22/2006 | CN1737103A Propolis wine |
| 02/22/2006 | CN1737008A Crystalline azithromycin, process for manufacture and pharmaceutical compositions thereof |
| 02/22/2006 | CN1736490A Tubercle bacillus chimeric gene vaccine and preparation process thereof |
| 02/22/2006 | CN1736482A Recombined chicken pox virus vaccine rFPV-12LSH5H9, its construction method and use |
| 02/22/2006 | CN1736481A Recombined chicken pox virus vaccine rPFV-12LSH9A, preparation process and use thereof |
| 02/22/2006 | CN1736480A Method for preparing aftosa vaccine |
| 02/22/2006 | CN1736470A Medicinal prescription of skin sterilizing formulation |
| 02/22/2006 | CN1736455A Chinese medicinal composition for treating tinea |